Enliven Therapeutics CMO Helen Louise Collins disposes of USD 262,213 in common sharesPUBT·Jul 21 at 04:23 PMELVN+0.27%
The Goldman Sachs Group Issues Positive Forecast for Enliven Therapeutics (NASDAQ:ELVN) Stock PriceMarket Beat·Jul 21 at 07:48 AMELVN+0.27%IVZ+0.44%
Biotech Stocks At 52-Week Highs- CDNA, IART, AGL, BVS, ELVNrttnews·Jul 17 at 04:18 AMIART+6.63%BVS+2.79%
Enliven Therapeutics director Lori Anne Kunkel disposes of USD 504,256 common sharesPUBT·Jul 8 at 04:18 PMELVN+0.27%
OrbiMed Advisors reports Enliven Therapeutics common stock sale worth $38.02 millionPUBT·Jun 24 at 06:20 PMELVN+0.27%
Enliven Therapeutics CMO Helen Louise Collins disposes of USD 217,816 in common sharesPUBT·Jun 22 at 04:12 PMELVN+0.27%
OrbiMed Advisors reports $12.67 million Enliven Therapeutics common stock salePUBT·Jun 17 at 06:46 PMELVN+0.27%
Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares | ELVN Stock NewsStockTitan·Jun 15 at 07:40 AMELVN+0.27%GS-D+0.31%
Top Biotech Gainers: SNSE Awaits Data In 2H, STTK To Begin Crohn's Trial In Q3, ALMS On Watchrttnews·Jun 14 at 09:09 PMALMS-1.06%TXMD0.00%
